Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.35 Million CAD | -5.5% |
| 2022 | 2.49 Million CAD | 84.34% |
| 2021 | 1.35 Million CAD | 29.79% |
| 2020 | 1.04 Million CAD | 10.52% |
| 2019 | 942.56 Thousand USD | 21.38% |
| 2018 | 776.53 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 911.31 Thousand CAD | 49.47% |
| 2024 Q1 | 609.68 Thousand CAD | 334.76% |
| 2023 Q2 | 793.76 Thousand USD | 5.34% |
| 2023 Q1 | 753.55 Thousand CAD | 7.81% |
| 2023 FY | 2.35 Million CAD | -5.5% |
| 2023 Q4 | -259.7 Thousand CAD | -135.12% |
| 2023 Q3 | 739.47 Thousand USD | -6.84% |
| 2022 Q3 | 647.14 Thousand CAD | -2.65% |
| 2022 Q2 | 664.74 Thousand CAD | 34.24% |
| 2022 Q1 | 495.17 Thousand CAD | 34.93% |
| 2022 FY | 2.49 Million CAD | 84.34% |
| 2022 Q4 | 698.96 Thousand CAD | 8.01% |
| 2021 Q2 | 331.89 Thousand CAD | 8.48% |
| 2021 Q3 | 356.24 Thousand CAD | 7.34% |
| 2021 Q4 | 366.98 Thousand CAD | 3.01% |
| 2021 FY | 1.35 Million CAD | 29.79% |
| 2021 Q1 | 305.95 Thousand CAD | 116.64% |
| 2020 FY | 1.04 Million CAD | 10.52% |
| 2020 Q4 | -1.83 Million CAD | -742.25% |
| 2020 Q3 | 286.2 Thousand CAD | 47.16% |
| 2020 Q2 | 194.49 Thousand CAD | -11.11% |
| 2020 Q1 | 218.8 Thousand CAD | -8.12% |
| 2019 Q2 | 266.51 Thousand CAD | 12.84% |
| 2019 Q4 | 238.14 Thousand CAD | -9.78% |
| 2019 Q1 | 236.18 Thousand CAD | 0.0% |
| 2019 Q3 | 263.94 Thousand CAD | -0.97% |
| 2019 FY | 942.56 Thousand USD | 21.38% |
| 2018 FY | 776.53 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 1320.342% |
| Arrayit Corporation | 2.57 Million USD | 8.536% |
| Atlantic International Corp. | -154.23 Thousand USD | 1627.07% |
| Biocept, Inc. | -2.58 Million USD | 191.218% |
| Bioqual, Inc. | 7.42 Million USD | 68.297% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -753.355% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.965% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -31.279% |
| iMD Companies, Inc. | -23.63 Thousand USD | 10064.297% |
| IDenta Corp. | 662.97 Thousand USD | -255.256% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 89.779% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -2936.265% |
| InVitro International | 635.98 Thousand USD | -270.333% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 64.113% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -115.548% |
| NovelStem International Corp. | 12 Thousand USD | -19527.175% |
| Optigenex Inc. | -102.96 Thousand USD | 2387.416% |
| PharmChem, Inc. | 3.9 Million USD | 39.676% |
| Proteome Sciences plc | 2.09 Million USD | -12.336% |
| Response Genetics, Inc | 3.94 Million USD | 40.252% |
| Rennova Health, Inc. | 6.26 Million USD | 62.426% |
| RushNet, Inc. | 1.1 Million USD | -113.22% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -174.963% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 683.351% |
| Todos Medical Ltd. | 4.31 Million USD | 45.354% |